Predicting Bleeding Risk by Platelet Function Testing in Patients Undergoing Heart Surgery.

Area of Science:

• Cardiovascular Surgery
• Hematology
• Clinical Diagnostics

Background:

• Predicting bleeding after coronary artery bypass grafting (CABG) is crucial for improving patient outcomes.
• Current methods for assessing bleeding risk in CABG patients have limitations.

Purpose of the Study:

• To investigate the association between platelet function tests and postoperative bleeding risk in patients undergoing CABG.
• To evaluate the predictive value of arachidonic acid (ASPI Test) and adenosine diphosphate (ADP Test) in assessing bleeding complications.

Main Methods:

• Retrospective analysis of 478 patients undergoing CABG, including those on aspirin and/or clopidogrel.
• Platelet aggregation was measured using the ASPI Test and ADP Test via multiple-electrode aggregometry before surgery.
• Clinical outcomes, including postoperative drainage and red blood cell concentrate transfusion, were recorded.

Main Results:

• An ASPI Test value below 407 AUC*min was associated with increased postoperative drainage in the overall study group.
• In CABG-only patients, an ASPI Test value below 271 AUC*min predicted the need for red blood cell concentrate transfusion.
• The ADP Test did not show prognostic utility for bleeding risk in patients who stopped clopidogrel within 5 days before surgery.

Conclusions:

• The ASPI Test may serve as a valuable tool for predicting postoperative bleeding complications after heart surgery.
• Specific ASPI Test thresholds can help identify patients at higher risk for excessive drainage or transfusion requirements following CABG.